Porter Hospital Dba Cedar Ledge Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 99 Court St, Cedar Lodge Family Practice, Middlebury, VT 05753 Phone: 802-388-7185 Fax: 802-388-3445 |
Green Mountain Primary Care Plc Family Medicine Medicare: Medicare Enrolled Practice Location: 102a Court St Ste A, Middlebury, VT 05753 Phone: 802-382-0849 Fax: 802-382-0144 |
Five-town Health Alliance, Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 56 College St, Middlebury, VT 05753 Phone: 802-453-5028 |
Porter Hospital Dba Addison Family Health Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 28 Catamount Drive, Addison Family Health, Middlebury, VT 05753 Phone: 802-388-7185 Fax: 802-388-3445 |
Porter Hospital Inc Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 115 Porter Drive, Porter Hospital, Middlebury, VT 05753 Phone: 802-388-5607 Fax: 802-388-5654 |
Porter Hospital Inc Dba Porter Internal Medicine Internal Medicine Medicare: Medicare Enrolled Practice Location: 116 Porter Drive, Porter Internal Medicine, Middlebury, VT 05753 Phone: 802-388-8805 Fax: 802-388-5619 |
Village Health, Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 5 Park St Ste 3a, Middlebury, VT 05753 Phone: 802-922-6538 |
News Archive
The Los Angeles County Office of Women's Health and the American Heart Association have launched a joint heart-health education and stroke prevention program targeting low-income women. Combined, heart disease and stroke account for over 50% of all deaths among Los Angeles County women.
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, another anticoagulant agent, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
If you were beginning to suspect that the list of things which could make you fat seems to be growing longer on an almost daily basis - you were right!
Using nanoparticles to engineer a special drug, a team of researchers from McGovern Medical School at The University of Texas Health Science Center at Houston has demonstrated in pre-clinical trials a new way to both reduce preterm birth and avoid the risks of medication in pregnancy to unborn babies.
In a study published in this week's New England Journal of Medicine, treatment with a new drug candidate known as VX-770 resulted in improvements in lung function and markers of disease in a Phase 2 clinical trial of 39 people with cystic fibrosis (CF). There were no discontinuations due to adverse events in the study, and the frequency of adverse events was similar across the study groups.
› Verified 7 days ago